News | February 28, 2008

New CRT-D, ICD Implants Treat Heart Failure, CAD

February 29, 2008 - Physicians began performing the first European implants of the COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter defibrillator (ICD) by Boston Scientific Corp. after both devices received CE Mark last month.

The COGNIS CRT-D and the TELIGEN ICD are small and thin high-energy devices, measuring 32.5 cc and 31.5 cc respectively, while less than 10 mm thick. They offer features based on significant engineering advances, including extended battery longevity, self-correcting software and improved programming technology. These devices are built on an entirely new technology platform and are the result of a multi-year research and development effort to provide physicians enhanced clinical options for their patients.

Forty implants have been performed in 14 hospitals in six countries.
This week’s implants represent the beginning of the market launch in Europe. The Company plans to build to a full launch in Europe and other international markets in the second quarter.

“The COGNIS CRT-D offers extended battery longevity and several new features that will help me better manage my heart failure patients,” said Poul-Erik Bloch-Thomsen, M.D., Gentofte Hospital, Hellerup, Denmark. “For example, the
SmartDelay feature recommends programmable device settings, which enable meto tailor individualized pacing therapies.”

The COGNIS CRT-D and the TELIGEN ICD are pending approval by the FDA and are not available for sale in the United States.

For more information: www.bostonscientific.com

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Overlay Init